VAXINANO

Vaxinano is a biotechnology company specializing in the pre-clinical and clinical development of human and veterinary vaccines. Vaxinano was created in 2016, based on 30 years of research and clinical trials in vaccinology using technology patented by Pr. Didier Betbeder... Vaxinano is positioning itself as the first company to be able to develop inactivated vaccines without adjuvants administered nasally, also with evidence of efficacy against influenza and covid-19... Vaxinano, based in Lille, is a biotechnology company specializing in the development of prophylactic and therapeutic vaccines to fight against infectious diseases in human and animal health. We offer a vaccine platform from which innovative, adjuvant-free vaccines are developed. This platform makes it possible to develop new vaccines, improve existing vaccines (replacement of adjuvants) and reduce/replace the use of antibiotics.

Also known as: Vaxinano Company, Vaxinano SE

Primary location: Loos France